HIGHLIGHTS
- who: ufeffZi-Aiufeff ufeffZhaoufeff et al. from the University of Freiburg Medical Center, Germany have published the research: Intra-arterial tenecteplase is safe and may improve the first-pass recanalization for acute ischemic stroke with large-artery atherosclerosis: the BRETIS-TNK trial, in the Journal: (JOURNAL)
- what: This study was designed to explore the safety, feasibility, and possible efficacy of the combination in this population. In the current study, TNK was chosen as the thrombolytic of choice based on recent findings that TNK may have better efficacy on clinical and imaging endpoints compared to alteplase . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.